Nearly three dozen buildings have been identified as potential sources of a life-threatening lung disease as dozens of people ...
aDepartment of Gastrointestinal Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada bDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer ...
First patient dosed with ZI-MA4-1 in the ZIMA-101 Phase 1 trial at The Christie NHS Foundation TrustZI-MA4-1 is the world’s first MAGE-A4-targeting TCR-NK therapy in clinical developmentZIMA-101 ...